Korean Digital Healthcare Landscape
Korean Digital Healthcare Landscape
Key Takeaway
Korea's December 2025 telemedicine legalization marks a structural inflection point for the country's digital health market, projected to reach USD $1.3 billion in 2026. Canadian companies with established telemedicine platforms, remote patient monitoring devices, or chronic disease management solutions are well-positioned to capitalize on immediate procurement demand from Korean hospitals and clinics.
# Korean Digital Healthcare Landscape
South Korea is emerging as one of the world's leading digital health markets, driven by a convergence of factors that few other countries can match: a technology-savvy population with near-universal smartphone penetration, a world-class hospital system eager to adopt cutting-edge technologies, government policies that are aggressively promoting digital health transformation, and a domestic AI medical device industry that is among the most advanced globally. For Canadian digital health companies, Korea represents both a high-potential market and a validation platform for technologies seeking global scale.
This report examines Korea's digital healthcare landscape in 2026, covering the telemedicine regulatory shift, AI diagnostic devices, the government's digital health roadmap, Software as a Medical Device (SaMD) regulation, wearable health devices, and the data infrastructure that underpins the ecosystem.
---
Part 1: Telemedicine — The Regulatory Breakthrough
The December 2025 Legalization
For decades, Korea was one of the few advanced economies where telemedicine was effectively prohibited for most clinical uses. Despite having the technological infrastructure to support remote healthcare delivery, regulatory restrictions limited telemedicine to narrow use cases (remote islands, military installations, and emergency situations). This regulatory gap was a significant structural barrier to digital health innovation.
In December 2025, Korea's National Assembly passed legislation legalizing telemedicine for a substantially broader range of clinical applications. While the law includes safeguards — requirements for initial in-person consultations before remote follow-ups, restrictions on prescribing controlled substances via telemedicine, and data security mandates — it represents a fundamental shift in Korea's healthcare delivery framework.
Market Impact
The telemedicine legalization has catalyzed investment and commercial activity across the digital health sector. The distance health technology sector is projected to reach a valuation of USD $1.3 billion in 2026 as the regulatory framework takes effect and healthcare providers begin implementing telemedicine platforms at scale.
Key implications include: